Spotlight On... EPFL team creates an industrial-scale platform for stem cells; Antibodies neutralize Ebola strains; New pathway for immune response; and more...

Scientists at the Ecole Polytechnique Fédérale de Lausanne say they have developed a new technique that uses a gel consisting of growth nutrients to "squeeze" cells into more malleable stem cells. This approach promises to create a new industrial-sized platform that can be used to manufacture large quantities of stem cells needed for a variety of applications. Release

> Researchers at Albert Einstein College of Medicine have created antibodies that were able to neutralize two of the most potent strains of Ebola in mice. Release

> Lung cells known as pulmonary neuroendocrine cells, or PNECs, can regulate an immune response, offering a new pathway for treating errant immune responses that cause diseases such as asthma. Release


Suggested Articles

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.